Autolus Therapeutics plc - American Depositary Share (AUTL) Social Stream
AUTOLUS THERAPEUTICS PLC (AUTL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AUTL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 6 | $21 | $7 | $13.2 | $7.29 | 81.07% |
| 2021-12-20 | 5 | $21 | $7 | $12.8 | $7.29 | 75.58% |
| 2022-03-31 | 6 | $21 | $7 | $12.8 | $7.29 | 75.58% |
| 2022-05-06 | 6 | $13 | $7 | $10.75 | $7.29 | 47.46% |
| 2022-05-16 | 5 | $13 | $7 | $10.75 | $7.29 | 47.46% |
| 2022-08-05 | 5 | $12 | $7 | $10.25 | $7.29 | 40.6% |
| 2022-08-18 | 6 | $12 | $7 | $10.6 | $7.29 | 45.4% |
| 2022-11-04 | 6 | $12 | $7 | $10.4 | $7.29 | 42.66% |
| 2022-12-09 | 6 | $12 | $7 | $9.4 | $7.29 | 28.94% |
| 2023-01-04 | 6 | $12 | $6 | $8.6 | $7.29 | 17.97% |
| 2023-03-08 | 7 | $12 | $6 | $8.833 | $7.29 | 21.17% |
| 2023-05-05 | 6 | $12 | $6 | $8.4 | $7.29 | 15.23% |
| 2023-08-04 | 7 | $12 | $5 | $7.833 | $7.29 | 7.45% |
| 2023-08-17 | 7 | $12 | $5 | $8.333 | $7.29 | 14.31% |
| 2023-11-02 | 6 | $12 | $6 | $9 | $7.29 | 23.46% |
| 2023-12-13 | 7 | $12 | $6 | $9.166 | $7.29 | 25.73% |
| 2023-12-29 | 8 | $12 | $4.8 | $8.542 | $7.29 | 17.17% |
The Trend in the Analyst Price Target
Over the past 28 days, AUTL's average price target has gone down $0.62.
AUTL reports an average of 166.28% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-11-21 | 7 | 12 | 6.0 | 9.166 | 4.05 | 126.32% |
| 2023-11-22 | 7 | 12 | 6.0 | 9.166 | 4.48 | 104.6% |
| 2023-11-24 | 7 | 12 | 6.0 | 9.166 | 4.80 | 90.96% |
| 2023-12-01 | 7 | 12 | 6.0 | 9.166 | 4.19 | 118.76% |
| 2023-12-18 | 8 | 12 | 4.8 | 8.542 | 5.18 | 64.9% |
AUTL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 6 | 1 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
AUTL's average broker recommendation rating improved by 0.36 over the prior 21 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how AUTOLUS THERAPEUTICS PLC fares relative to all US stocks, note that its average analyst price target is higher than 216.87% of that group.
- AUTL has a lower variance in analysts' estimates than -1419.77% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AUTOLUS THERAPEUTICS PLC's upside potential (average analyst target price relative to current price) is higher than 579% of them.
- AUTOLUS THERAPEUTICS PLC's number of analysts covering the stock is greater than 1395.72% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AUTOLUS THERAPEUTICS PLC are AVRO, MGTX, and SRRK.
View All Top Stocks by Price Target
Is AUTL a Buy, Hold or Sell? See the POWR Ratings now!